SUVEN

Suven Life Sciences

₹147.86
+ 7.04 (5%)
27 July, 2024 10:19 BSE: 530239 NSE: SUVEN ISIN: INE495B01038

Start SIP in Suven Life Sciences

Start SIP

Suven Life Sciences Performance

Day Range

  • Low 140
  • High 148
₹ 147

52 Week Range

  • Low 61
  • High 148
₹ 147
  • Open Price141
  • Previous Close141
  • Volume808720

Suven Life Sciences Share Price

  • Over 1 Month + 43.37%
  • Over 3 Month + 32.67%
  • Over 6 Month + 36.15%
  • Over 1 Year + 134.33%

Suven Life Sciences Key Statistics

P/E Ratio -30.7
PEG Ratio -2.8
Market Cap Cr
Price to Book Ratio 11.9
EPS -0.9
Dividend 0
Relative Strength Index 72.73
Money Flow Index 75.49
MACD Signal 8.25
Average True Range 7.35
Suven Life Sciences Financials
IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 22343
Operating Expenses Qtr Cr 91211119
Operating Profit Qtr Cr -7-9-8-7-6
Depreciation Qtr Cr 22222
Interest Qtr Cr 00000
Tax Qtr Cr -10000
Net Profit Qtr Cr -3-53-3-2
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 3322
Operating Expenses Annual Cr 4341
Operating Profit Annual in Cr -31-28
Depreciation Cr 77
Interest Annual Cr 00
Tax Annual Cr -10
Net Profit Annual Cr -8-20
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr -21-10
Cash from Investing Activity Annual Cr -1-362
Cash from Financing Annual Activity Cr -1396
Net Cash Flow Annual Cr -2224
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 845853
Fixed Assets Annual Cr 2837
Total Non Current Assets Annual Cr 605619
Total Current Assets Annual Cr 246241
Total Assets Annual Cr 851860
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 3939
ROE Annual % -1-2
ROCE Annual % -2-3
Total Debt to Total Equity Annual --
EBDIT Annual Margin % -84-143
IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 22343
Operating Expenses Qtr Cr 3349273234
Operating Profit Qtr Cr -30-46-24-28-32
Depreciation Qtr Cr 22222
Interest Qtr Cr 00000
Tax Qtr Cr -10000
Net Profit Qtr Cr -27-42-13-24-28
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 3322
Operating Expenses Annual Cr 140139
Operating Profit Annual in Cr -128-126
Depreciation Cr 77
Interest Annual Cr 00
Tax Annual Cr -10
Net Profit Annual Cr -105-118
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr -115-103
Cash from Investing Activity Annual Cr 94-261
Cash from Financing Annual Activity Cr -1396
Net Cash Flow Annual Cr -2232
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 270375
Fixed Assets Annual Cr 2837
Total Non Current Assets Annual Cr 28137
Total Current Assets Annual Cr 257252
Total Assets Annual Cr 285389
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 1217
ROE Annual % -39-32
ROCE Annual % -42-33
Total Debt to Total Equity Annual --
EBDIT Annual Margin % -914-867

Suven Life Sciences Technicals

EMA & SMA

Current Price
₹147.86
+ 7.04 (5%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹128.37
  • 50 Day
  • ₹116.87
  • 100 Day
  • ₹109.66
  • 200 Day
  • ₹100.26
  • 20 Day
  • ₹128.32
  • 50 Day
  • ₹109.75
  • 100 Day
  • ₹108.10
  • 200 Day
  • ₹99.48

Suven Life Sciences Resistance and Support

PIVOT
₹145.13
Resistance
First Resistance 150.59
Second Resistance 153.33
Third Resistance 158.79
RSI 72.73
MFI 75.49
MACD Single Line 8.25
MACD 8.88
Support
First Support 142.39
Second Support 136.93
Third Supoort 134.19

Suven Life Sciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,055,634 67,043,315 63.51
Week 607,482 36,995,642 60.9
1 Month 914,749 50,109,976 54.78
6 Month 372,550 26,290,888 70.57

Suven Life Sciences Result Highlights

Suven Life Sciences Synopsis

NSE-Medical-Diversified

Suven Life Sciences is involved in the business activities of Other professional, scientific and technical activities. Company’s Total Operating Revenue is Rs. 11.69 Cr. and Equity Capital is Rs. 21.81 Cr. for the Year ended 31/03/2024. Suven Life Sciences Ltd. is a Public Limited Listed company incorporated on 09/03/1989 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24110TG1989PLC009713 and registration number is 009713.
Market Cap 3,224
Sales 12
Shares in Float 6.54
No of funds 14
Yield 0.89
Book Value 3.81
U/D Vol ratio 3.3
LTDebt / Equity
Alpha 0.24
Beta 1.07

Suven Life Sciences Shareholding Pattern

Owner NameJun-24Mar-24Dec-23Sep-23
Promoters 70.27%69.57%69.57%69.57%
Mutual Funds 1.05%1.05%0.01%0.01%
Foreign Portfolio Investors 0.45%0.46%0.54%0.5%
Financial Institutions/ Banks
Individual Investors 22.65%22.3%24.05%24.38%
Others 5.58%6.62%5.83%5.54%

Suven Life Sciences Management

Name Designation
Mr. Venkateswarlu Jasti Chairman & Managing Director
Mrs. Sudharani Jasti Whole Time Director
Prof. Seyed E Hasnain Director
Mr. Santanu Mukherjee Director
Mrs. J A S Padmaja Director
Dr. Vajja Sambasiva Rao Director

Suven Life Sciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Suven Life Sciences Corporate Action

Date Purpose Remarks
2024-05-06 Audited Results
2024-01-30 Quarterly Results
2023-11-04 Quarterly Results
2023-08-08 Quarterly Results
2023-05-09 Audited Results

Suven Life Sciences MF Shareholding

Suven Life Sciences FAQs

What is Share Price of Suven Life Sciences ?

Suven Life Sciences share price is ₹147 As on 27 July, 2024 | 10:05

What is the Market Cap of Suven Life Sciences ?

The Market Cap of Suven Life Sciences is ₹3224.4 Cr As on 27 July, 2024 | 10:05

What is the P/E ratio of Suven Life Sciences ?

The P/E ratio of Suven Life Sciences is -30.7 As on 27 July, 2024 | 10:05

What is the PB ratio of Suven Life Sciences ?

The PB ratio of Suven Life Sciences is 11.9 As on 27 July, 2024 | 10:05

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91